JPRN-UMIN000014328
Completed
Phase 1
Hypofractionated radiotherapy for low and intermediate-risk prostate cancer using robot-tracking stereotactic radiotherapy -phase I/II clinical trial- - Robot-tracking stereotactic radiotherapy for prostate cancer
Conditionsprostate cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- prostate cancer
- Sponsor
- Osaka University Graduate School of Medicine
- Enrollment
- 75
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Active double cancer 2\) Uncontrollable DM 3\) Impossible to stop anticoagulate drugs 4\) Severe brain disease 5\) Collagen disease 6\) Previous pelvic surgery or radiotherapy 7\) Previous TUR\-P 8\) Severe BPH or dysuria 9\) Disagree to implant of metallic marker 10\) Hormone therapy \> 1 year 11\) Castration\-resistant prostate cancer 12\) PSA \>20 13\) Physician\-rated contraindication
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Standard moderately hypofractionated radiotherapy vs. ultra-hypofractionated focal lesion ablative microboost in prostate cancer, Hypo-FLAME 3.0prostate cancer10038597NL-OMON56327Antoni van Leeuwenhoek Ziekenhuis352
Completed
Phase 2
Intensity-modulated, hypofractionated radiotherapy with scanning beam protons for locally advanced carcinoma of the prostate and localized carcinoma of the prostate with risk factors - a phase II studyC61Malignant neoplasm of prostateDRKS00011912Westdeutsches Protonentherapiezentrum Essen (WPE)133
Recruiting
Phase 2
Two-fraction Ultra-hypofractionated Radiotherapy with Focal Boost for low- and intermediate risk, localized prostate cancer (TURBO):phase II, randomized controlled clinical trialprostate adenocarcinomaprostate cancer100276561001818810036958NL-OMON56580niversitair Medisch Centrum Utrecht160
Completed
Phase 2
Hypofractionated stereotactic radiotherapy for large brain metastasesBrain metastasesJPRN-UMIN000010112Department of Radiology, Nagoya City University Graduate School of Medical Sciences90
Active, not recruiting
Not Applicable
Sequential hypofractionated radiotherapy followed by anti-PD-L1 atezolizumab for recurrent or refractory small cell lung cancerKCT0005443ational Cancer Center35